JMP Securities Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Achillion Enters Into Worldwide Collaboration for Hepatitis C With Janssen
May 19, 2015 4:05 PM EDT- Transactions include up to $1.1 billion in potential development, regulatory and sales milestone payments and a separate equity investment -
- Achillion eligible for tiered royalties between mid-teens and low-twenties on future worldwide sales -
- Janssen responsible for all development costs within the collaboration and all subsequent costs related to commercialization of the assets -
- Conference call scheduled for today at 5:00 p.m. ET -
NEW HAVEN, Conn., May 19, 2015 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:... More
